EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Patient and Technology Selection for Focal Therapy in Prostate Cancer

Mustafa Dinckal iD, Rodrigo Rodrigues Pessoa iD, Julio Pow-Sang iD, Alice Yu iD

Cancers · 25.06.2026 · 18 (13) · 2070

DOI: 10.3390/cancers18132070 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.06.2026. Verfasst von Mustafa Dinckal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kars Harakani State Hospital, Kars 36200, Turkey. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Focal therapy is emerging as an organ-preserving strategy for selected patients with localized prostate cancer, aiming to preserve urinary and sexual function while maintaining acceptable cancer control. However, patient and technology selection remain complex because prostate cancer is often multifocal, clinically significant lesions may be missed by imaging or biopsy, and long-term comparative oncological data are limited. This narrative review summarizes current evidence and consensus recommendations on oncological suitability, histopathological risk features, tumor burden, imaging assessment, anatomical considerations, functional priorities, and follow-up. We also discuss the complementary roles of multiparametric magnetic resonance imaging, prostate-specific membrane antigen positron emission tomography, micro-ultrasound, and artificial intelligence-assisted planning. Finally, we review how tumor location and proximity to critical structures guide selection among high-intensity focused ultrasound, cryotherapy, irreversible electroporation, transurethral ultrasound ablation, laser ablation, and photodynamic therapy. Focal therapy remains promising but requires careful selection, shared decision-making, and structured follow-up.

Schlagwörter

Stichwörter der Autor:innen

PSMA PET scanfocal therapymultiparametric MRIprostate biopsyprostate cancer

Autor:innen und Institutionen

  • Department of Urology, Kars Harakani State Hospital, Kars 36200, Turkey.
  • Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.

ORCID-Profile: Mustafa Dinckal, Rodrigo Rodrigues Pessoa, Julio Pow-Sang, Alice Yu

Zitieren

APA

Dinckal, M., Rodrigues Pessoa, R., Pow-Sang, J., & Yu, A. (2026). Patient and Technology Selection for Focal Therapy in Prostate Cancer. Cancers, 18(13), 2070. https://doi.org/10.3390/cancers18132070

Vancouver

Dinckal M, Rodrigues Pessoa R, Pow-Sang J, Yu A. Patient and Technology Selection for Focal Therapy in Prostate Cancer. Cancers. 2026;18(13):2070. doi:10.3390/cancers18132070

BibTeX
@article{Dinckal2026,
  author = {Dinckal, Mustafa and Rodrigues Pessoa, Rodrigo and Pow-Sang, Julio and Yu, Alice},
  title = {Patient and Technology Selection for Focal Therapy in Prostate Cancer},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {13},
  pages = {2070},
  doi = {10.3390/cancers18132070}
}
Kostenlos starten →